Prognostic significance of radiologically determined neck node volume in head and neck cancer: A systematic review

Oral Oncology

Volumn 48, Issue 4, 2012, Pages 298-302

  Lodder, W L ^a   Pameijer, F A ^b   Rasch, C R N ^a   Van Den Brekel, M W M ^a,c   Balm, A J M ^a,c  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Head and neck cancer; Nodal volumes; Prognosis; Survival; Total tumor volume

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CERVICAL LYMPH NODE; CHEMORADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONSENSUS DEVELOPMENT; HEAD AND NECK CANCER; HUMAN; LYMPH NODE VOLUME; MATHEMATICAL COMPUTING; MEDICAL LITERATURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY TUMOR; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TUMOR VOLUME;

DISEASE-FREE SURVIVAL; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; NECK; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR BURDEN;

EID: 84859445230     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2011.11.001     Document Type: Review

References (35)

1. van den Broek GB, Rasch CR, Pameijer FA, Peters E, van den Brekel MWM, Tan IB, et al. Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma. Cancer 2004;101:1809-17. (Pubitemid 39314744)
2. Knegjens JL, Hauptmann M, Pameijer FA, Balm AJ, Hoebers FJ, de Bois JA, et al. Tumor volume as prognostic factor in chemoradiation for advanced head and neck cancer. Head Neck 2010;33:375-82.
3. Pameijer FA, Mancuso AA, Mendenhall WM, Parsons JT, Kubilis PS. Can pretreatment computed tomography predict local control in T3 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy? Int J Radiat Oncol Biol Phys 1997;37:1011-21. (Pubitemid 27230024)
4. Lodder WL, Teertstra HJ, Tan IB, Pameijer FA, Smeele LE, van Velthuysen ML, et al. Tumour thickness in oral cancer using an intra-oral ultrasound probe. Eur Radiol 2011;21:98-106.
5. Pentenero M, Gandolfo S, Carrozzo M. Importance of tumor thickness and depth of invasion in nodal involvement and prognosis of oral squamous cell carcinoma: a review of the literature. Head Neck 2005;27:1080-91. (Pubitemid 41705587)
6. Po Wing Yuen A, Lam KY, Lam LK, Ho CM, Wong A, Chow TL, et al. Prognostic factors of clinically stage I and II oral tongue carcinoma-A comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, Martinez-Gimeno score, and pathologic features. Head Neck 2002;24:513-20. (Pubitemid 34568551)
7. Shaw RJ, Lowe D, Woolgar JA, Brown JS, Vaughan ED, Evans C, et al. Extracapsular spread in oral squamous cell carcinoma. Head Neck 2010;32:714-22.
8. Dunne AA, Muller HH, Eisele DW, Kessel K, Moll R, Werner JA. Meta-analysis of the prognostic significance of perinodal spread in head and neck squamous cell carcinomas (HNSCC) patients. Eur J Cancer 2006;42:1863-8. (Pubitemid 44149097)
9. Woolgar JA. Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol 2006;42:229-39. (Pubitemid 43246755)
10. Edge SBB, Compton CC, Fritz AG, Greene FL, Trotti A. American Joint Committee of Cancer - AJCC Cancer Staging Manual. Springer; 2010.
11. Doweck I, Denys D, Robbins T. Tumor volume predicts outcome for advanced head and neck cancer treated with targeted chemoradiotherapy. Laryngoscope 2002;112:1742-9.
12. Chen SW, Yang SN, Liang JA, Lin FJ, Tsai MH. Prognostic impact of tumor volume in patients with stage III-IVA hypopharyngeal cancer without bulky lymph nodes treated with definitive concurrent chemoradiotherapy. Head Neck 2009;31:709-16.
13. Grabenbauer GG, Steininger H, Meyer M, Fietkau R, Brunner T, Heinkelmann P, et al. Nodal CT density and total tumor volume as prognostic factors after radiation therapy of stage III/IV head and neck cancer. Radiother Oncol 1998;47:175-83. (Pubitemid 28275928)
14. Chufal KS, Rastogi M, Srivastava M, Pant MC, Bhatt ML, Srivastava K. Analysis of prognostic variables among patients with locally advanced head and neck cancer treated with late chemo-intensification protocol: impact of nodal density and total tumor volume. Jpn J Clin Oncol 2006;36:537-46. (Pubitemid 44593895)
15. Dietz A, Delorme S, Rudat V, Zuna I, Conradt C, Vanselow B, et al. Prognostic assessment of sonography and tumor volumetry in advanced cancer of the head and neck by use of doppler ultrasonography. Otolaryngol Head Neck Surg 2000;122:596-601. (Pubitemid 30210684)
16. Dunst J, Stadler P, Becker A, Lautenschlager C, Pelz T, Hansgen G, et al. Tumor volume and tumor hypoxia in head and neck cancers. The amount of the hypoxic volume is important. Strahlenther Onkol 2003;179:521-6. (Pubitemid 36966408)
17. Hermans R, Op de beeck K, Van den Bogaert W, Rijnders A, Staelens L, Feron M, et al. The relation of CT-determined tumor parameters and local and regional outcome of tonsillar cancer after definitive radiation treatment. Int J Radiat Oncol Biol Phys 2001;50:37-45.
18. Hermans R, Van den Bogaert W, Rijnders A, Baert AL. Value of computed tomography as outcome predictor of supraglottic squamous cell carcinoma treated by definitive radiation therapy. Int J Radiat Oncol Biol Phys 1999;44:755-65. (Pubitemid 29284124)
19. Jakobsen J, Hansen O, Jorgensen KE, Bastholt L. Lymph node metastases from laryngeal and pharyngeal carcinomas-calculation of burden of metastasis and its impact on prognosis. Acta Oncol 1998;37:489-93. (Pubitemid 28505993)
20. Johnson CR, Khandelwal SR, Schmidt-Ullrich RK, Ravalese J, Wazer DE. The influence of quantitative tumor volume measurements on local control in advanced head and neck cancer using concomitant boost accelerated superfractionated irradiation. Int J Radiat Oncol Biol Phys 1995;32:635-41.
21. Kuhnt T, Mueller AC, Pelz T, Haensgen G, Bloching M, Koesling S, et al. Impact of tumor control and presence of visible necrosis in head and neck cancer patients treated with radiotherapy or radiochemotherapy. J Cancer Res Clin Oncol 2005;131:758-64. (Pubitemid 41577953)
22. Kurek R, Kalogera-Fountzila A, Muskalla K, Dafni U, Schnabel T, Kober B, et al. Usefulness of tumor volumetry as a prognostic factor of survival in head and neck cancer. Strahlenther Onkol 2003;179:292-7. (Pubitemid 36606019)
23. La TH, Filion EJ, Turnbull BB, Chu JN, Lee P, Nguyen K, et al. Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer. Int J Radiation Oncology Biol Phys 2009;74:1335-41.
24. Ljumanovic R, Langendijk JA, Hoekstra OS, Leemans CR, Castelijns JA. Distant metastases in head and neck carcinoma: identification of prognostic groups with MR imaging. Eur J Radiol 2006;60:58-66. (Pubitemid 44404160)
25. Morris MM, Schmidt-Ullrich RK, DiNardo L, Manning MA, Silverman L, Clay L, et al. Accelerated superfractionated radiotherapy with concomitant boost for locally advanced head-and-neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 2002;52:918-28. (Pubitemid 34219009)
26. Plataniotis GA, Theofanopoulou ME, Kalogera-Fountzila A, Haritanti A, Ciuleanou E, Ghilezan N, et al. Prognostic impact of tumor volumetry in patients with locally advanced head-and-neck carcinoma (nonnasopharyngeal) treated by radiotherapy alone or combined radiochemotherapy in a randomized trial. Int J Radiat Oncol Biol Phys 2004;59: 1018-26. (Pubitemid 38834294)
27. Rudat V, Dietz A, Schramm O, Conradt C, Maier H, Flentje M, et al. Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy. Radiother Oncol 1999;53:119-25.
28. Tsou YA, Hua JH, Lin MH, Tsai MH. Analysis of prognostic factors of chemoradiation therapy for advanced hypopharyngeal cancer-does tumor volume correlate with central necrosis and tumor pathology? ORL J Otorhinolaryngol Relat Spec 2006;68:206-12.
29. Van den Bogaert W, van der Schueren E, Horiot JC, de Vilhena M, Schraub S, Svoboda V, et al. The EORTC randomized trial on three fractions per day and misonidazole in advanced head and neck cancer: prognostic factors. Radiother Oncol 1995;35:100-6.
30. Vergeer MR, Doornaert P, Leemans CR, Buter J, Slotman BJ, Langendijk JA. Control of nodal metastases in squamous cell head and neck cancer treated by radiation therapy or chemoradiation. Radiother Oncol 2006;79:39-44.
31. Brown J, Buckley D, Coulthard A, Dixon AK, Dixon JM, Easton DF, et al. Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study. UK MRI Breast Screening Study Advisory Group. Magn Reson Imaging 2000;18:765-76.
32. Barentsz JO, Jager GJ, van Vierzen PB, Witjes JA, Strijk SP, Peters H, et al. Staging urinary bladder cancer after transurethral biopsy: value of fast dynamic contrast-enhanced MR imaging. Radiology 1996;201:185-93. (Pubitemid 26314386)
33. Alderliesten T, Schlief A, Peterse J, Loo C, Teertstra H, Muller S, et al. Validation of semiautomatic measurement of the extent of breast tumors using contrastenhanced magnetic resonance imaging. Invest Radiol 2007;42:42-9. (Pubitemid 46072551)
34. Hadjiiski L, Mukherji SK, Ibrahim M, Sahiner B, Gujar SK, Moyer J, et al. Head and neck cancers on CT: preliminary study of treatment response assessment based on computerized volume analysis. AJR Am J Roentgenol 2010;194:1083-9.
35. Moher D, Liberati A, Tetzlaff J, ALtman DG. PRISMA group. Preffered reporting items for systematic review and meta-analyses: the PRISMA statement. BMJ 2009;339:2535.